Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05177991 · ClinicalTrials.gov registry record · Early Phase 1
Post-operative Pain Control-TAP Block Using Exparel vs. Marcaine for Hernia Repairs
A Early Phase 1 study of Ventral Hernia and Inguinal Hernia, sponsored by Leslie Son.
- Active
- Registry status
- Early Phase 1
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT05177991 is a Early Phase 1 study of Ventral Hernia and Inguinal Hernia that is active but no longer recruiting, run by Leslie Son. The registered enrollment target is 200 participants, above the 132-participant average among 18 other Ventral Hernia trials with a reported enrollment target (52% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05177991, a Early Phase 1 study of Ventral Hernia and Inguinal Hernia, is active but no longer recruiting, sponsored by Leslie Son.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
While studies have shown improved postoperative pain control with TAP blocks after inguinal and ventral hernia repair, data comparing Liposomal bupivacaine (Exparel) to bupivacaine alone in formulation of the TAP block is particularly scarce. Therefore, we designed a prospective, randomized trial comparing the postoperative pain control in minimally invasive ventral and inguinal hernia repair patients who receive an Exaparel-based TAP block compared to the traditional bupivacaine (Marcaine) TAP block.
Conditions Studied
Interventions
- DRUG Bupivacaine
- DRUG Liposomal Bupivacaine
Study Locations (1)
Louisiana
- Karl LeBlanc - Baton Rouge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2022-03-01 |
| Est. Completion | 2025-12-31 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05177991
The ClinicalTrials.gov registry entry for NCT05177991 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 132-participant average among 18 other Ventral Hernia trials with a reported enrollment target (52% higher). The listed sponsor is Leslie Son, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Ventral Hernia appearing as the primary indexed condition, and to 2 interventions - of which Bupivacaine is the first listed.
NCT05177991 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.
Frequently Asked Questions
What is clinical trial NCT05177991 about?
NCT05177991 is a clinical study titled "Post-operative Pain Control-TAP Block Using Exparel vs. Marcaine for Hernia Repairs". While studies have shown improved postoperative pain control with TAP blocks after inguinal and ventral hernia repair, data comparing Liposomal bupivacaine (Exparel) to bupivacaine alone in formulation of the TAP block is particularly scarce. Therefore, we designed a prospective, randomized trial co...
What is the current status of trial NCT05177991?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 200 participants. The study started on 2022-03-01. Estimated completion is 2025-12-31.
What conditions does trial NCT05177991 study?
This clinical trial studies the following conditions: Ventral Hernia, Inguinal Hernia.
What interventions are being tested in trial NCT05177991?
The interventions under investigation include: Bupivacaine (DRUG), Liposomal Bupivacaine (DRUG).
Who is sponsoring clinical trial NCT05177991?
This trial is sponsored by Leslie Son, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05177991 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ventral Hernia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
AFFIX: Post-market Study of MaxTack™ Motorized Fixation Device in Subjects Undergoing Ventral Hernia Repair
RECRUITING · NA
-
Robotic Versus Open Ventral Hernia Repair
RECRUITING · NA
-
Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants Undergoing Open Abdominal Ventral Hernia Repair
RECRUITING · Phase 2
-
Clinical Investigation of the da Vinci Surgical System
ACTIVE NOT RECRUITING · NA
-
Methocarbamol in Ventral and Inguinal HR
ACTIVE NOT RECRUITING · Phase 4
-
Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Hernia Surgery (Enable Hernia Repair)
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.